1408 ET - Cantor says the price that Core Scientific shareholders are getting in Coreweave's acquisition "appears low." According to the deal, Core shareholders will receive 0.1235 shares of Coreweave, equating to $20.40 a share based on Coreweave's closing price on Thursday. Core Scientific is currently off 17% to $14.85 while Coreweave is down 3.8% to $158.96, implying that Core is trading at a steep discount, the analysts say. "We believe the market is under-appreciating what Core Scientific's deal with CoreWeave is worth, as well as additional capacity it currently has available for AI/HPC [high-performance computing]," the analysts say.(katherine.hamilton@wsj.com)
(END) Dow Jones Newswires
July 07, 2025 14:08 ET (18:08 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.